SG Americas Securities LLC Sells 5,076 Shares of R1 RCM Inc. (NASDAQ:RCM)

SG Americas Securities LLC lowered its position in shares of R1 RCM Inc. (NASDAQ:RCM) by 29.9% during the third quarter, Holdings Channel.com reports. The firm owned 11,916 shares of the healthcare provider’s stock after selling 5,076 shares during the quarter. SG Americas Securities LLC’s holdings in R1 RCM were worth $169,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Advisors Asset Management Inc. acquired a new position in shares of R1 RCM during the 1st quarter worth approximately $27,000. ANTIPODES PARTNERS Ltd bought a new position in R1 RCM during the 2nd quarter worth $86,000. QRG Capital Management Inc. acquired a new position in R1 RCM in the 1st quarter valued at $132,000. CIBC Asset Management Inc bought a new stake in shares of R1 RCM during the 2nd quarter valued at $149,000. Finally, Covestor Ltd lifted its position in shares of R1 RCM by 340.9% during the 1st quarter. Covestor Ltd now owns 13,438 shares of the healthcare provider’s stock valued at $172,000 after acquiring an additional 10,390 shares during the period. 61.10% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently commented on RCM shares. Morgan Stanley downgraded R1 RCM from an “overweight” rating to an “equal weight” rating in a research note on Thursday, August 8th. Royal Bank of Canada restated an “outperform” rating and issued a $19.00 target price on shares of R1 RCM in a research report on Friday, June 28th. Robert W. Baird reiterated an “outperform” rating and set a $18.00 price target on shares of R1 RCM in a research report on Tuesday, July 2nd. Truist Financial lowered their price objective on shares of R1 RCM from $16.00 to $14.30 and set a “hold” rating for the company in a research report on Thursday, August 8th. Finally, Leerink Partnrs downgraded R1 RCM from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. Thirteen research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $15.41.

R1 RCM Stock Up 0.0 %

NASDAQ:RCM opened at $14.24 on Thursday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.84 and a quick ratio of 1.84. R1 RCM Inc. has a one year low of $8.87 and a one year high of $15.12. The firm’s 50 day simple moving average is $14.13 and its 200 day simple moving average is $13.15. The company has a market cap of $6.00 billion, a PE ratio of -178.00 and a beta of 0.85.

R1 RCM (NASDAQ:RCM) last issued its quarterly earnings data on Wednesday, August 7th. The healthcare provider reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.03. The company had revenue of $627.90 million for the quarter, compared to analysts’ expectations of $633.10 million. R1 RCM had a negative net margin of 1.68% and a negative return on equity of 1.44%. The business’s quarterly revenue was up 12.0% on a year-over-year basis. On average, research analysts anticipate that R1 RCM Inc. will post -0.24 earnings per share for the current year.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.